Mark Hopman sold $16K of Beta Bionics stock

By AlphaYouPublished Oct 28, 2026Form 4

Stocks in this disclosure

Reported activity

Hopman Mark

Reporting filer

Mark Hopman reported selling 821 shares of Beta Bionics, Inc. for about $16K ($20.00 a share on average). Form 4 filed Oct 28, 2026 lists 1 entry.

Reported details

1 entry

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Common Stock	Hopman Mark	2026-10-26	S	Sale	821.00	20.00	54,513	2 days	Filed terms security Title: Common Stock transaction Date: 2026-10-26 deemed Execution Date: transaction Form Type: 4 transaction Code: S equity Swap Involved: false id: F1 transaction Timeliness: transaction Shares: 821.00 transaction Price Per Share: 20.00 transaction Acquired Disposed Code: D shares Owned Following Transaction: 54513.00 direct Or Indirect Ownership: D

Owner: Hopman Mark
Date: 2026-10-26
Code: S
Action: Sale
Quantity: 821.00
Price: 20.00
Following holdings: 54,513
Reporting delay: 2 days
Filed terms and references: Filed terms
security Title: Common Stock
transaction Date: 2026-10-26
deemed Execution Date:
transaction Form Type: 4
transaction Code: S
equity Swap Involved: false
id: F1
transaction Timeliness:
transaction Shares: 821.00
transaction Price Per Share: 20.00
transaction Acquired Disposed Code: D
shares Owned Following Transaction: 54513.00
direct Or Indirect Ownership: D

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
Hopman Mark: Chief Commercial Officer.
The filing reports a Rule 10b5-1 trading plan.
F1: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on June 10, 2026.

Prepared automatically from public filing data. Report a correction.